Stem Cell
June FDA memo reaffirms guidelines from 2017 in regard to human cell, tissue product use
Clinicians need to be aware of the contents of the June 3 memo from the FDA regarding use of human cell and tissue products and must realize that the guidance issued Nov. 15, 2017, has not changed, according to a regulatory consultant.
PRP point-of-care devices prove effective for isolating stem cells from synovial fluid
NASHVILLE, Tenn. — Stem cells can successfully be isolated from synovial fluid in knees with acute ACL tears or osteoarthritis at the point of care using devices designed for platelet-rich plasma processing, according to study results.
Top in rheumatology: Mesenchymal stem cell injections, digital approaches in OA care
A speaker at the 2021 OARSI World Congress said that synovial mesenchymal stem cell injections can suppress cartilage loss in patients with progressive osteoarthritis. It was the top story in rheumatology last week.
Mesenchymal stem cell injections represent cutting edge of OA intervention
Intra-articular injections of mesenchymal stem cells into the synovium may yield expression of a number of genes that inhibit progression of osteoarthritis, according to a speaker at the 2021 OARSI World Congress virtual meeting.
American Association for Cancer Research honors stem cell biology expert
American Association for Cancer Research has recognized Hans Clevers, MD, PhD, FAACR, with the 2021 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research.
High-dose chemo plus stem cell transplant effective for CNS lymphoma
Triplex vaccine reduces CMV complications in stem cell transplant recipients
The novel Triplex vaccine induced immunity to cytomegalovirus, or CMV, and reduced rates of complications from the virus in patients undergoing allogeneic hematopoietic stem cell transplant, according to results from a phase 2 randomized clinical trial published in Annals of Internal Medicine.
AACR-MPM Oncology Charitable Foundation awards grants to cancer researchers
ACR, Arthritis Foundation guidelines favor nondrug therapy over TENS, stem cells for OA
ATLANTA — Health care providers should avoid prescribing transcutaneous electric nerve stimulation or stem cell injections in favor of more comprehensive management — including nonpharmacological interventions such as tai chi — for hip, knee and hand osteoarthritis, according to draft guidelines presented at ACR/ARP 2019.